Non-linear Pharmacokinetics & Michaelis-Menten MCQs With Answer

Introduction

Non-linear Pharmacokinetics & Michaelis-Menten MCQs With Answer is designed for M.Pharm students preparing for MIP 201T – Advanced Biopharmaceutics & Pharmacokinetics. This quiz collection focuses on capacity‑limited processes, Michaelis‑Menten kinetics, saturation of metabolism and transport, and clinical implications for dosing and therapeutic monitoring. Questions range from conceptual principles (Vmax, Km, intrinsic clearance) to practical problem‑solving (dose proportionality, accumulation, parameter estimation and graphical methods). Each MCQ includes four options and the correct answer, helping you test understanding, reinforce learning, and prepare for exams and viva. Use these items to identify weak areas and to deepen your comprehension of non‑linear PK behavior.

Q1. Which statement best describes Michaelis‑Menten pharmacokinetics in the context of drug metabolism?

• Clearance remains constant regardless of concentration
• Elimination follows first‑order kinetics at all concentrations
• Elimination rate approaches a maximum (Vmax) as concentration increases
• Absorption rate is independent of enzyme capacity

Correct Answer: Elimination rate approaches a maximum (Vmax) as concentration increases

Q2. In Michaelis‑Menten kinetics, what does Km represent?

• The maximum elimination rate achieved at saturating concentration
• The concentration at which elimination rate is half of Vmax
• The clearance at steady state
• The elimination rate constant at low concentrations

Correct Answer: The concentration at which elimination rate is half of Vmax

Q3. For a drug following Michaelis‑Menten elimination, intrinsic clearance (CLint) is best approximated by which expression at concentrations much lower than Km?

• Vmax / [S + Km]
• Vmax × Km
• Vmax / Km
• Km / Vmax

Correct Answer: Vmax / Km

Q4. Which clinical implication is typical for a drug that displays saturable (non‑linear) metabolism at therapeutic concentrations?

• Doubling the dose always doubles steady‑state concentration
• Half‑life remains constant across doses
• Small dose increases may produce disproportionately large increases in plasma concentrations
• Clearance increases with increasing dose

Correct Answer: Small dose increases may produce disproportionately large increases in plasma concentrations

Q5. Which graphical transformation linearizes Michaelis‑Menten data by plotting 1/velocity vs 1/substrate concentration?

• Hanes‑Woolf plot
• Eadie‑Hofstee plot
• Lineweaver‑Burk plot
• Scatchard plot

Correct Answer: Lineweaver‑Burk plot

Q6. When a drug’s elimination is saturated (concentration >> Km), which kinetic order predominates?

• First‑order kinetics
• Zero‑order kinetics
• Pseudo‑first‑order kinetics
• Mixed‑order kinetics with constant half‑life

Correct Answer: Zero‑order kinetics

Q7. If Vmax = 50 mg/hr and Km = 10 mg/L, what is the approximate clearance at a plasma concentration of 1 mg/L (assume MM kinetics)?

• Approximately 50 L/hr
• Approximately 5 L/hr
• Approximately 0.2 L/hr
• Approximately 0.91 L/hr

Correct Answer: Approximately 5 L/hr

Q8. Which parameter changes with dose or concentration for drugs exhibiting Michaelis‑Menten kinetics?

• Vmax
• Km
• Apparent clearance
• Protein binding constant

Correct Answer: Apparent clearance

Q9. For multiple dosing of a drug with saturable elimination, which statement is true regarding steady‑state attainment?

• Time to steady state is independent of dose and remains constant
• Time to steady state increases predictably with each dose increment
• Time to steady state may change with dose because elimination rate and half‑life are concentration‑dependent
• Steady state is never achieved for nonlinear drugs

Correct Answer: Time to steady state may change with dose because elimination rate and half‑life are concentration‑dependent

Q10. Which situation is most likely to produce non‑linearity due to saturable renal processes?

• Passive glomerular filtration of a small unbound molecule
• Renal tubular secretion mediated by active transporters at high concentrations
• Distribution into a large tissue compartment
• Protein binding changes at low concentrations

Correct Answer: Renal tubular secretion mediated by active transporters at high concentrations

Q11. Which equation describes the Michaelis‑Menten elimination rate (v) as a function of concentration [C]?

• v = Vmax × [C] / (Km + [C])
• v = CL × [C]
• v = k × [C]^2
• v = Vmax × Km / [C]

Correct Answer: v = Vmax × [C] / (Km + [C])

Q12. A drug exhibits apparent clearance (CLapp) that decreases with increasing concentration. Which kinetic behavior does this indicate?

• Induction of metabolism
• Saturable (capacity‑limited) elimination
• Increased renal filtration
• Enhanced hepatic blood flow‑limited clearance

Correct Answer: Saturable (capacity‑limited) elimination

Q13. When estimating Vmax and Km from in vivo data using an Eadie‑Hofstee plot, what is plotted on the x and y axes?

• x = 1/[S], y = 1/v
• x = v, y = v/[S]
• x = v/[S], y = v
• x = [S], y = v

Correct Answer: x = v/[S], y = v

Q14. Which of the following best defines target‑mediated drug disposition (TMDD)?

• Disposition determined solely by renal excretion
• Nonlinear PK resulting from high‑affinity binding to a pharmacologic target affecting clearance
• Linear pharmacokinetics at all therapeutic concentrations
• Elimination that follows simple first‑order kinetics due to passive diffusion

Correct Answer: Nonlinear PK resulting from high‑affinity binding to a pharmacologic target affecting clearance

Q15. For a drug with Km = 5 mg/L, which plasma concentration will produce an elimination rate approximately equal to 75% of Vmax?

• Approximately 1.67 mg/L
• Approximately 5 mg/L
• Approximately 15 mg/L
• Approximately 2.5 mg/L

Correct Answer: Approximately 15 mg/L

Q16. Which approach is most appropriate to detect nonlinearity in single‑dose PK studies?

• Compare dose‑normalized AUCs across multiple doses
• Rely solely on half‑life reported at one dose
• Measure only peak concentration at one dose
• Use protein binding data only

Correct Answer: Compare dose‑normalized AUCs across multiple doses

Q17. In clinical dosing, which strategy can mitigate risk when administering a drug with saturable elimination?

• Increase dose frequency without changing individual dose
• Use small incremental dose adjustments and therapeutic drug monitoring
• Switch to a higher single loading dose
• Ignore concentration measurements because they are unpredictable

Correct Answer: Use small incremental dose adjustments and therapeutic drug monitoring

Q18. If a drug shows non‑proportional increase in AUC with increasing dose, which mathematical relationship best describes this observation?

• AUC ∝ Dose (proportional)
• AUC increases less than proportionally due to increased clearance
• AUC increases more than proportionally due to saturable clearance
• AUC is independent of dose

Correct Answer: AUC increases more than proportionally due to saturable clearance

Q19. Which experimental evidence would most strongly support Michaelis‑Menten elimination rather than simple first‑order elimination?

• Constant CL and linear AUC increase with dose
• Dose‑dependent change in half‑life and disproportionate AUC increase
• Peak concentration proportional to dose while AUC remains constant
• No change in Cmax or AUC across doses

Correct Answer: Dose‑dependent change in half‑life and disproportionate AUC increase

Q20. Which of the following relationships is true when drug concentration [C] equals Km in Michaelis‑Menten kinetics?

• Elimination rate = Vmax
• Elimination rate = Vmax/2
• Clearance = Vmax
• Apparent clearance equals zero

Correct Answer: Elimination rate = Vmax/2

Download